Ophthotech Corporation (NASDAQ:OPHT) David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, presented an overview of the Company at the Barclays Capital Global Healthcare Conference in Miami on Tuesday, March 11, 2014 at 9:30 a.m. Eastern Time. Ophthotech Corp (NASDAQ:OPHT) shares after opening at $31.47 moved to $32.98 on last trade day and at the end of the day closed at $32.14. Company price to cash ratio in past twelve months was calculated as 4.54. Ophthotech Corp (NASDAQ:OPHT) showed a negative weekly performance of -3.19%.
Tandem Diabetes Care Inc (NASDAQ:TNDM) issued a press release announcing our financial results for the fourth quarter and fiscal year ended December 31, 2013, and providing certain other information. Tandem Diabetes Care Inc (NASDAQ:TNDM) shares fell -1.97% in last trading session and ended the day on $19.44. Tandem Diabetes Care Inc (NASDAQ:TNDM) return on equity ratio is recorded as 108.30% and its return on assets is -92.70%.
PTC Therapeutics, Inc. (NASDAQ:PTCT) announced its financial results for the quarter and fiscal year ended December 31, 2013. PTC Therapeutics, Inc. (NASDAQ:PTCT) shares moved down -6.04% in last trading session and was closed at $22.40 while trading in range of $21.34 – $24.88 – PTC Therapeutics, Inc. (NASDAQ:PTCT) year to date (YTD) performance is 32.00%.
The Medicines Company’s (NASDAQ:MDCO) shares dropped 15.48% after the U.S. District Court of Delaware found thatHospira Inc.’s (HSP) generic version of The Medicines Co.’s Angiomax (bivalirudin) does not infringe the patents. Angiomax is used as an anticoagulant in patients undergoing coronary angioplasty. The Medicines Company (NASDAQ:MDCO) weekly performance is -12.04%. On last trading day company shares ended up $24.54. The Medicines Company (NASDAQ:MDCO) distance from 50-day is -20.83%. Analysts mean target price for the company is $33.73.